Cargando…
The role of RNA modification in the generation of acquired drug resistance in glioma
Glioma is the most common malignant tumor in the central nervous system. The clinical treatment strategy is mainly surgery combined with concurrent temozolomide chemotherapy, but patients can develop drug resistance during treatment, which severely limits its therapeutic efficacy. Epigenetic regulat...
Autores principales: | Yan, Yu, Wei, Wei, Long, Shengrong, Ye, Shengda, Yang, Bin, Jiang, Jiazhi, Li, Xiang, Chen, Jincao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692093/ https://www.ncbi.nlm.nih.gov/pubmed/36437944 http://dx.doi.org/10.3389/fgene.2022.1032286 |
Ejemplares similares
-
Insights into the regulatory role of RNA methylation modifications in glioma
por: Long, Shengrong, et al.
Publicado: (2023) -
CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas
por: Wang, Bo, et al.
Publicado: (2022) -
Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses
por: Ye, Shengda, et al.
Publicado: (2022) -
Competing Endogenous RNA Networks in Glioma
por: Cen, Liang, et al.
Publicado: (2021) -
Research Progress for RNA Modifications in Physiological and Pathological Angiogenesis
por: Chen, Hui-Ming, et al.
Publicado: (2022)